Literature DB >> 7004372

Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity.

F H Messerli, B Christie, J G DeCarvalho, G G Aristimuno, D H Suarez, G R Dreslinski, E D Frohlich.   

Abstract

Systemic hemodynamics, intravascular volume, and plasma renin activity were determined in 135 lean, midly obese, or distinctly overweight subjects who were normotensive or had borderline or established essential hypertension. Cardiac output (but not index) was higher and peripheral resistance lower in obese than in lean subjects, except in borderline hypertension. Intravascular volume was increased in obese patients, and more so when corrected for body height; correction for body weight led to relative volume contraction. Intravascular volume correlated directly with cardiac output in the entire population, as well as in the subgroups. Intravascular volume correlated inversely with total peripheral resistance in all subjects and in each subgroup. Both correlations remained significant when an approximation was used to correct influences of obesity on total blood volume. Sodium excretion was higher in obese than in lean subjects. Thus, despite the expanded intravascular volume in obesity, the pathophysiologic relationship between systemic hemodynamics and intravascular volumes remains unchanged. Relatively low peripheral resistance in obesity may decrease the risk of systemic vascular disease. Nevertheless, since circulating volume is increased, the greater venous return adds an additional load to a left ventricle that is already burdened by a high afterload caused by arterial hypertension.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7004372     DOI: 10.1001/archinte.141.1.81

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  46 in total

Review 1.  The metabolic syndrome and related cardiovascular risk.

Authors:  F Ramos; H P Baglivo; A J Ramírez; R Sánchez
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

2.  Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study).

Authors:  Showkat A Haji; Rifat Eralp Ulusoy; Dharmendrakumar A Patel; Sathanur R Srinivasan; Wei Chen; Patrice Delafontaine; Gerald S Berenson
Journal:  Am J Cardiol       Date:  2006-09-07       Impact factor: 2.778

3.  Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms.

Authors:  M L Tuck; M S Golub; P Eggena; J R Sowers; M Maxwell
Journal:  West J Med       Date:  1983-08

Review 4.  The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.

Authors:  Zohreh Soltani; Vaughn Washco; Stephen Morse; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

5.  Antihypertensive treatment in patients with class 3 obesity.

Authors:  Jens Jordan; Sam W Boye; Stephanie Le Breton; Deborah L Keefe; Stefan Engeli; Margaret Forney Prescott
Journal:  Ther Adv Endocrinol Metab       Date:  2012-06       Impact factor: 3.565

6.  Hypertension research program at ochsner: a program in translational research.

Authors:  Edward Frohlich
Journal:  Ochsner J       Date:  2002

7.  Association of body composition with bone mineral density in northern Chinese men by different criteria for obesity.

Authors:  D H Kang; L F Guo; T Guo; Y Wang; T Liu; X Y Feng; X Q Che
Journal:  J Endocrinol Invest       Date:  2014-09-25       Impact factor: 4.256

8.  Obesity and preclinical changes of cardiac geometry and function.

Authors:  Joong Kyung Sung; Jang-Young Kim
Journal:  Korean Circ J       Date:  2010-02-23       Impact factor: 3.243

9.  Adiposity and stroke among older adults of low socioeconomic status: the Chicago Stroke Study.

Authors:  L DiPietro; A M Ostfeld; G L Rosner
Journal:  Am J Public Health       Date:  1994-01       Impact factor: 9.308

10.  The impact of weight loss on cardiac structure and function in obese patients.

Authors:  Mohsin Syed; Carl Rosati; Mikhail T Torosoff; Mohammad El-Hajjar; Paul Feustel; Sharon Alger; Paul Singh; Steven Fein
Journal:  Obes Surg       Date:  2008-09-09       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.